Abbott's $335 M HIV buy

Article Abstract:

Abbott Park, IL-based Abbott Laboratories will significantly expand its antiviral portfolio with a deal involving Durham, NC-based Triangle Pharmaceuticals. Abbott presently owns two HIV proteaseinhibitors (Norvir, approved and ABT-378, in phase III development). Triangle owns three nucleoside reverse transcriptase inhibitors and one non-nucleoside reverse transcriptase inhibitor for treatment of HIV and HBV. Abbott will buy Triangle shares and provide $31.7 million in research funding. Both companies will share profits.

Receipt of funds, Pharmaceutical Preparation Manufacturing, Antiinfective Preparations, Alliances, partnerships, Use of Funds, Anti-infective agents, Abbott Laboratories (Abbott Park, Illinois), Triangle Pharmaceuticals Inc.

---

Warner Lambert acquires speculative Agouron pipeline

Article Abstract:

Warner-Lambert acquired San Diego, California-based Agouron Pharmaceuticals for $2.1 billion in stock.

California, Drugs, Brief Article, Warner-Lambert Co., WLA, Agouron Pharmaceuticals Inc., AGPH

---

Similar abstracts:

• Abstracts: Something out of the blue. Emerging markets: equities back in favour. Are the markets trying to tell us something?
• Abstracts: Global equities: crash unlikely. Wall Street hopes for an upturn. The five trillion dollar burden of bias
• Abstracts: 2005 world's best banks. Best banks in project finance
• Abstracts: Winds of change. Happ Controls: Selling name recognition in Europe
• Abstracts: A bank after your own heart. Private banks seek personal touch. Banking on added value

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.